As a part of this work, we assessed changes in protein modifications following PGRMC1 signal inhibition by AG-205 or PGRMC1 silencing in both ZR-75-1 and MDA-MB-468 breast cancer cell lines (Fig. 4a, b). Here, PGRMC1 is linked to breast cancer.